Literature DB >> 18855901

Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.

Alphonse E Sirica1, Michael H Nathanson, Gregory J Gores, Nicholas F Larusso.   

Abstract

In June 2008, the American Association for the Study of Liver Diseases (AASLD) sponsored the Henry M. and Lillian Stratton Basic Research Single-Topic Conference on the Pathobiology of Biliary Epithelia and Cholangiocarcinoma, which was held in Atlanta, GA. Attendees from 12 different countries participated in this conference, making it a truly international scientific event. Both oral and poster presentations were given by multidisciplinary experts, who highlighted important areas of current basic and translational research on biliary epithelial cell biology and pathophysiology, and on the etiology, cellular and molecular pathogenesis, and target-based therapy of cholangiocarcinoma. The specific goals and objectives of the conference were: (1) to advance knowledge of basic and molecular mechanisms underlying developmental and proliferative disorders of the biliary tract; (2) to foster a better and more comprehensive understanding of mechanisms regulating biliary epithelial (cholangiocyte) growth and transport, signaling, cell survival, and abnormalities that result in disease; and (3) to understand basic mechanisms of cholangiocarcinoma development and progression, with the added goal of identifying and exploiting potentially critical molecular pathways that may be targeted therapeutically. A number of interrelated themes emerged from the oral and poster sessions that affected current understandings of the complex organization of transcriptional and signaling mechanisms that regulate bile duct development, hepatic progenitor cell expansion, cholangiocyte secretory functions and proliferation, and mechanisms of cholangiocarcinogenesis and malignant cholangiocyte progression. Most notable were the critical questions raised as to how best to exploit aberrant signaling pathways associated with biliary disease as potential targets for therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18855901      PMCID: PMC3724356          DOI: 10.1002/hep.22623

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  56 in total

1.  Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.

Authors:  Luca Fabris; Massimiliano Cadamuro; Romina Fiorotto; Tania Roskams; Carlo Spirlì; Saida Melero; Aurelio Sonzogni; Ruth E Joplin; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

Review 2.  Cdc25: mechanisms of checkpoint inhibition and recovery.

Authors:  Christina Karlsson-Rosenthal; Jonathan B A Millar
Journal:  Trends Cell Biol       Date:  2006-05-08       Impact factor: 20.808

3.  Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers.

Authors:  Scott A Ochsner; Hélène Strick-Marchand; Qiong Qiu; Susan Venable; Adam Dean; Margaret Wilde; Mary C Weiss; Gretchen J Darlington
Journal:  Stem Cells       Date:  2007-07-19       Impact factor: 6.277

4.  Suppression of C/EBPalpha expression in periportal hepatoblasts may stimulate biliary cell differentiation through increased Hnf6 and Hnf1b expression.

Authors:  Harufumi Yamasaki; Aiko Sada; Takeyuki Iwata; Tohru Niwa; Minoru Tomizawa; Kleanthis G Xanthopoulos; Toru Koike; Nobuyoshi Shiojiri
Journal:  Development       Date:  2006-10-04       Impact factor: 6.868

5.  Domain-specific purinergic signaling in polarized rat cholangiocytes.

Authors:  K D Salter; J G Fitz; R M Roman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-03       Impact factor: 4.052

6.  Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.

Authors:  Xiaoling Xu; Shogo Kobayashi; Wenhui Qiao; Cuiling Li; Cuiying Xiao; Svetlana Radaeva; Bangyan Stiles; Rui-Hong Wang; Nobuya Ohara; Tadashi Yoshino; Derek LeRoith; Michael S Torbenson; Gregory J Gores; Hong Wu; Bin Gao; Chu-Xia Deng
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

7.  Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma.

Authors:  Naoki Matsumura; Masakazu Yamamoto; Atsushi Aruga; Ken Takasaki; Masayuki Nakano
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

8.  Liver regeneration in acute severe liver impairment: a clinicopathological correlation study.

Authors:  Aezam Katoonizadeh; Frederik Nevens; Chris Verslype; Jacques Pirenne; Tania Roskams
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

9.  Transdifferentiation into biliary ductular cells of hepatocytes transplanted into the spleen.

Authors:  Hirofumi Watanabe; Masaki Hata; Nobuyuki Terada; Haruyasu Ueda; Naoko Yamada; Koji Yamanegi; Hideki Ohyama; Michiko Kakihana; Haruki Okamura; Keiji Nakasho
Journal:  Pathology       Date:  2008-04       Impact factor: 5.306

10.  Notch signaling regulates bile duct morphogenesis in mice.

Authors:  Julie Lozier; Brent McCright; Thomas Gridley
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

View more
  14 in total

Review 1.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

2.  The Neuropeptide Galanin Is Up-Regulated during Cholestasis and Contributes to Cholangiocyte Proliferation.

Authors:  Matthew McMillin; Gabriel Frampton; Stephanie Grant; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2017-02-11       Impact factor: 4.307

3.  Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.

Authors:  L Yang; S Feng; Y Yang
Journal:  Cancer Gene Ther       Date:  2016-11-18       Impact factor: 5.987

Review 4.  Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.

Authors:  D Sia; V Tovar; A Moeini; J M Llovet
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

Review 5.  A shift in paradigm towards human biology-based systems for cholestatic-liver diseases.

Authors:  Fozia Noor
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

6.  Cholangiocarcinoma: improving biliary drainage with PDT.

Authors:  Michael H Chapman; Stephen P Pereira
Journal:  Photodiagnosis Photodyn Ther       Date:  2009-08-08       Impact factor: 3.631

Review 7.  Pathogenesis, diagnosis, and management of cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  Gastroenterology       Date:  2013-10-15       Impact factor: 22.682

8.  Novel organotypic culture model of cholangiocarcinoma progression.

Authors:  Deanna J W Campbell; Catherine I Dumur; Nadia F Lamour; Jennifer L Dewitt; Alphonse E Sirica
Journal:  Hepatol Res       Date:  2012-05-09       Impact factor: 4.288

Review 9.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

Review 10.  Pathophysiological Significance of Hepatic Apoptosis.

Authors:  Kewei Wang; Bingliang Lin
Journal:  ISRN Hepatol       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.